LLY

Eli Lilly & Co
D

LLY

Arincen80/100B

Eli Lilly & Co cash flow statement 1989–2026

Eli Lilly & Co's free cash flow over the last twelve months was 19.66B USD: operating cash flow of 30.64B USD less 10.98B USD of capital spending. That is 22.7% of its revenue and 21.96 a share.

Operating cash flow Free cash flow

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Net income
27.58B20.64B10.59B5.24B6.24B5.58B6.19B8.32B3.23B-204.10M2.74B
Depreciation and amortization
2.17B2.00B1.77B1.53B1.52B1.55B1.32B1.23B1.61B1.57B1.50B
Stock-based compensation
698.10M626.00M645.60M628.50M371.10M342.80M308.10M312.40M279.50M281.30M255.30M
Change in working capital
-5.57B-8.09B-5.39B-3.06B-800.00K-1.01B-747.40M-1.69B-2.38B3.20B-484.10M
Change in receivables
—-7.00B-2.16B-2.45B-299.60M-1.28B-1.35B-127.20M-10.76B-357.00M-5.09B
Change in inventory
—-4.67B-2.51B-1.43B-599.70M-235.90M-533.40M-258.70M7.80M-253.90M-328.20M
Change in payables
—10.19B2.61B4.27B1.33B-1.01B1.27B-477.70M-284.50M916.30M819.00M
Change in other working capital
-5.57B-6.61B-3.33B-3.45B-433.20M1.52B-135.10M-823.60M8.66B2.90B4.11B
Other non-cash items
7.61B3.35B3.88B2.24B1.63B1.71B-444.20M-3.40B2.46B1.55B406.10M
Operating cash flow
30.64B16.81B8.82B4.24B7.59B7.37B6.50B4.84B5.52B5.62B4.85B
Operating cash flow growth
+90.79%+90.67%+107.96%-44.10%+2.98%+13.33%+34.38%-12.45%-1.62%+15.76%+63.63%
Capital expenditure
-10.98B-7.84B-5.06B-7.39B-2.99B-1.98B-2.03B-1.35B-3.02B-2.16B-1.09B
Acquisitions
-10.80B-661.00M-947.70M-1.04B-327.20M-747.40M-849.30M-6.94B0.00-882.10M-45.00M
Purchases of investments
-989.00M-645.00M-775.80M-829.00M-707.60M-1.01B-370.10M-290.20M-950.10M-8.00B-5.67B
Sales and maturities of investments
—964.00M522.50M700.30M463.60M847.40M886.80M746.40M6.06B7.44B3.73B
Other investing
-7.77B-2.79B303.10M-2.53B-1.34B-644.30M102.80M-248.70M-2.00B-175.10M-56.70M
Investing cash flow
-30.41B-10.97B-9.30B-7.15B-3.76B-2.87B-2.26B-8.08B1.91B-3.78B-3.14B
Debt issued (repaid)
7.32B8.05B8.90B8.65B-62.00M501.40M291.60M4.69B-729.30M3.00B2.50B
Shares issued
—0.000.000.000.000.000.000.001.66B0.000.00
Share buybacks
-5.84B-4.11B-2.50B-750.00M-1.50B-1.25B-500.00M-4.40B-4.15B-299.80M-600.10M
Dividends paid
-5.98B-5.38B-4.68B-4.07B-3.54B-3.09B-2.69B-2.41B-2.31B-2.19B-2.16B
Other financing
-637.10M-772.00M-490.60M-335.00M-308.90M-295.90M-241.60M-200.10M-372.80M-364.40M-300.80M
Financing cash flow
-5.14B-2.21B1.23B3.50B-5.41B-4.13B-3.14B-2.32B-5.90B142.60M-559.80M
Net change in cash
-4.91B4.00B449.80M751.60M-1.75B161.40M1.32B-5.66B1.46B1.95B915.70M
Free cash flow
19.66B8.97B3.76B-3.15B4.60B5.39B4.47B3.48B2.51B3.45B3.76B
Free cash flow growth
+117.95%+138.62%—-168.52%-14.61%+20.51%+28.35%+38.97%-27.40%-8.17%+180.86%
Free cash flow margin
22.74%13.77%8.35%-9.24%16.12%19.02%18.22%15.61%11.66%17.28%17.71%
Free cash flow per share
21.969.994.16-3.495.095.914.673.642.423.283.41
Free cash flow per share growth
+119.25%+140.23%—-168.62%-13.94%+26.45%+28.47%+50.02%-26.11%-3.90%+181.98%
Income taxes paid
—0.000.000.000.000.000.000.000.000.000.00

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about Eli Lilly & Co's cash flow

Source: Financial Modeling Prep